Onychomycosis: An Updated Review
- PMID: 31738146
- PMCID: PMC7509699
- DOI: 10.2174/1872213X13666191026090713
Onychomycosis: An Updated Review
Abstract
Background: Onychomycosis is a common fungal infection of the nail.
Objective: The study aimed to provide an update on the evaluation, diagnosis, and treatment of onychomycosis.
Methods: A PubMed search was completed in Clinical Queries using the key term "onychomycosis". The search was conducted in May 2019. The search strategy included meta-analyses, randomized controlled trials, clinical trials, observational studies, and reviews published within the past 20 years. The search was restricted to English literature. Patents were searched using the key term "onychomycosis" in www.freepatentsonline.com.
Results: Onychomycosis is a fungal infection of the nail unit. Approximately 90% of toenail and 75% of fingernail onychomycosis are caused by dermatophytes, notably Trichophyton mentagrophytes and Trichophyton rubrum. Clinical manifestations include discoloration of the nail, subungual hyperkeratosis, onycholysis, and onychauxis. The diagnosis can be confirmed by direct microscopic examination with a potassium hydroxide wet-mount preparation, histopathologic examination of the trimmed affected nail plate with a periodic-acid-Schiff stain, fungal culture, or polymerase chain reaction assays. Laboratory confirmation of onychomycosis before beginning a treatment regimen should be considered. Currently, oral terbinafine is the treatment of choice, followed by oral itraconazole. In general, topical monotherapy can be considered for mild to moderate onychomycosis and is a therapeutic option when oral antifungal agents are contraindicated or cannot be tolerated. Recent patents related to the management of onychomycosis are also discussed.
Conclusion: Oral antifungal therapies are effective, but significant adverse effects limit their use. Although topical antifungal therapies have minimal adverse events, they are less effective than oral antifungal therapies, due to poor nail penetration. Therefore, there is a need for exploring more effective and/or alternative treatment modalities for the treatment of onychomycosis which are safer and more effective.
Keywords: Dermatophytes; itraconazole; nail discoloration; onychauxis; onycholysis; subungual hyperkeratosis; terbinafine..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Figures
Similar articles
-
Update on current approaches to diagnosis and treatment of onychomycosis.Expert Rev Anti Infect Ther. 2018 Dec;16(12):929-938. doi: 10.1080/14787210.2018.1544891. Epub 2018 Nov 13. Expert Rev Anti Infect Ther. 2018. PMID: 30411650 Review.
-
Onychomycosis: Diagnosis and management.Indian J Dermatol Venereol Leprol. 2011 Nov-Dec;77(6):659-72. doi: 10.4103/0378-6323.86475. Indian J Dermatol Venereol Leprol. 2011. PMID: 22016272 Review.
-
Trichophytum rubrum endonyx onychomycosis resistant to standard oral and topical therapies.Dermatol Online J. 2015 Sep 17;21(9):13030/qt3jb3t80q. Dermatol Online J. 2015. PMID: 26437286
-
Onychomycosis by Paecilomyces lilacinus.G Ital Dermatol Venereol. 2016 Dec;151(6):706-709. G Ital Dermatol Venereol. 2016. PMID: 27824223
-
Tinea Capitis: An Updated Review.Recent Pat Inflamm Allergy Drug Discov. 2020;14(1):58-68. doi: 10.2174/1872213X14666200106145624. Recent Pat Inflamm Allergy Drug Discov. 2020. PMID: 31906842 Review.
Cited by
-
Structure-activity relationship studies of ME1111, a novel antifungal agent for topical treatment of onychomycosis.J Antibiot (Tokyo). 2024 Nov 14. doi: 10.1038/s41429-024-00789-1. Online ahead of print. J Antibiot (Tokyo). 2024. PMID: 39543334
-
Combined fractional CO2 laser with topical tioconazole versus Q-switched Nd-YAG laser in the treatment of onychomycosis; a randomized comparative trial.Lasers Med Sci. 2024 Nov 12;39(1):274. doi: 10.1007/s10103-024-04214-9. Lasers Med Sci. 2024. PMID: 39528688 Free PMC article. Clinical Trial.
-
Antifungal Activity of Tea Tree (Melaleuca alternifolia Cheel) Essential Oils against the Main Onychomycosis-Causing Dermatophytes.J Fungi (Basel). 2024 Sep 27;10(10):675. doi: 10.3390/jof10100675. J Fungi (Basel). 2024. PMID: 39452627 Free PMC article.
-
Treatments for Onychomycosis: A Bibliometric Analysis.Skin Appendage Disord. 2024 Oct;10(5):383-390. doi: 10.1159/000539822. Epub 2024 Jul 20. Skin Appendage Disord. 2024. PMID: 39359745
-
Nail Lacquer Containing Origanum vulgare and Rosmarinus officinalis Essential Oils and Biogenic Silver Nanoparticles for Onychomycosis: Development, Characterization, and Evaluation of Antifungal Efficacy.Antibiotics (Basel). 2024 Sep 17;13(9):892. doi: 10.3390/antibiotics13090892. Antibiotics (Basel). 2024. PMID: 39335065 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
